U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. Public Health Focus
  4. Expanded Access
  5. Expanded Access (Compassionate Use) Submission Data
  1. Expanded Access

Expanded Access (Compassionate Use) Submission Data

CDER, CBER and CDRH Expanded Access INDs and Protocols (2016-2020)

On this page you will find:

  • The Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) expanded access submission receipt reports for INDs and Protocols from 2016-2020
  • The Center for Devices and Radiological Health (CDRH) expanded access requests from 2016-2020

The reports are broken down to the following:

FY 2016 – 2020 (most recent 5 years) Graphs of Expanded Access Submissions

To view the graph select the appropriate link below.

For older graphs, see archive page.

Expanded Access INDs for CDER and CBER (2016-2020)

Expanded Access INDs
 
Individual (Single)
Patient Non-Emergency
IND
Individual (Single) Patient
Emergency IND
Intermediate
Size IND
Treatment
IND
received allowed
to proceed
received allowed
to proceed
received allowed
to proceed
received allowed
to proceed
FY 2020 CDER 1034 1014 1779 1776 6 4 5 2
CBER 137 126 6292 6285 25 24 14 12
FY 2019 CDER 1083 1080 366 366 20 18 4 1
CBER 101 100 141 140 3 2 2 2
FY 2018 CDER 925 922 366 366 12 11 1 1
CBER 123 52* 162 162 8 7 1 1
FY 2017 CDER 1111 1107 461 461 36 35 0 0
CBER 40 36 80 70 11 10 2 2
FY 2016 CDER 997 992 473 473 37 33 0 0
CBER 28 27 90 90 5 5 4 2

* In FY18, CBER received a large number of single patient expanded access submissions for non-emergency use of the same product, for which FDA determined the risks associated with its use would be unreasonable for the patients involved or there was insufficient information to make a determination. Excluding these submissions, 91% of CBER’s non-emergency single patient expanded access submissions received were allowed to proceed.

For tables with older data, see archive page.

back to top


Expanded Access Protocols for CDER and CBER (2016-2020)

 Expanded Access Protocols
 
Individual (Single)
Patient Non-emergency
Protocol
Individual (Single) Patient
Emergency Protocol
Intermediate
Size Protocol
Treatment
Protocol
received allowed
to proceed
received allowed
to proceed
received allowed
to proceed
received allowed
to proceed
FY 2020 CDER 10 10 10 10 26 26 19 18
CBER 23 23 41 40 12 9 1 0
FY 2019 CDER 28 28 21 21 14 13 18 18
CBER 52 52 33 33 5 4 4 4
FY 2018 CDER 27 27 20 20 14 14 5 5
CBER 27 27 28 28 5 5 3 3
FY 2017 CDER 14 14 4 4 4 4 7 7
CBER 25 25 42 42 4 4 1 1
FY 2016 CDER 16 16 6 6 6 6 10 10
CBER 43 40 27 27 4 3 2 2

FY 2016 – 2020 Graphs of Expanded Access Submissions

CDER Expanded Access INDs and Protocol (2016-2020)

CDER Expanded Access IND Submissions Fiscal Year (FY) 2016 - 2020

 

CDER Expanded Access Protocol Submissions Fiscal Year (FY) 2016 - 2020

CBER Expanded Access INDs and Protocols (2016-2020)

CBER Expanded Access IND Submissions Fiscal Year (FY) 2016 - 2020

 

CBER Expanded Access Protocol Submissions Fiscal Year (FY) 2016 - 2020

Combined CDER and CBER Expanded Access Submissions and Protocols (2016-2020)

CBER and CDER Expanded Access IND Submissions Fiscal Year (FY) 2016 - 2020

 

CBER and CDER Expanded Access Protocol Submissions Fiscal Year (FY) 2016 - 2020

back to top


CDRH Expanded Access Requests (2016-2020)

FY 2016-2020 Graph of CDRH Expanded Access Requests

CDRH Expanded Access Requests Fiscal Year (FY) 2016 - 2020

CDRH IDE Expanded Access Requests (2016-2020)

Expanded Access Totals
  FY 2016 FY 2017 FY 2018 FY 2019 FY 2020
Requested Received 136 100 79 76 92
Evaluable Requests 124 96 69 69 89
Approved 123 96 69 67 89
Percentage Approved 99.2% 100.0% 100.0% 97.1% 100%

CDRH Non-IDE Expanded Access Requests(2016-2020)1

Expanded Access Totals
  FY 2016 FY 2017 FY 2018 FY 2019 FY 2020
Requested Received 198 230 257 352 384
Evaluable Requests2 196 220 233 335 372
Approved 196 220 232 332 372
Percentage Approved3 100.0% 100.0% 99.6% 99.1% 100%

1 Expanded Access requests outside of an IDE are limited to single patient compassionate use requests.
2 Evaluable requests are requests in which a substantive review was performed on an original, non-IDE compassionate use request resulting in an approval or disapproval decision.
3 Based on approved requests to total number of evaluable requests.

back to top

 

 

Back to Top